Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes

Dear Editor, we would like to congratulate Dr. Perkovic and colleagues demonstrating that semaglutide reduced by 24% the risk of kidney outcomes and death from cardiovascular causes in persons with type 2 diabetes (T2D) and chronic kidney disease (CKD)1. In SUSTAIN 6, semaglutide showed renal benefi...

Full description

Autores:

Rico-Fontalvo, Jorge
Daza-Arnedo, Rodrigo
Rodríguez-Yánez, Tomas
Soler, María J.

Tipo de recurso:

Fecha de publicación:

2024

Institución:

Universidad Simón Bolívar

Repositorio:

Repositorio Digital USB

Idioma:

eng

OAI Identifier:

oai:bonga.unisimon.edu.co:20.500.12442/16064

Acceso en línea:

https://hdl.handle.net/20.500.12442/16064
https://dx.doi.org/10.24875/NEFRO.24000031
https://www.nefrologialatinoamericana.com/files/es/nefro_24_21_3_096-097.pdf

Palabra clave:

Type 2 diabetes
Chronic kidney disease

Rights

openAccess

License

Attribution-NonCommercial-NoDerivs 3.0 United States